Showing results (2151-2160 of 25,162) with videos related to
Sort By:
Pageof 2,517
Oncotarget|June 15, 2018
Camptothecin exhibits topoisomerase1-independent KMT1A suppression and myogenic differentiation in alveolar rhabdomyosarcoma cellsDavid W Wolff, Min-Hyung Lee, Mathivanan Jothi, et al.Oncotarget|June 15, 2018
Metformin exerts antitumor activity via induction of multiple death pathways in tumor cells and activation of a protective immune responseFelipe V Pereira, Amanda Campelo L Melo, Jun Siong Low, et al.Oncotarget|June 15, 2018
Clinical validation of the Tempus xO assayNike Beaubier, Robert Tell, Robert Huether, et al.Oncotarget|June 15, 2018
Synthetic lethality in CCNE1-amplified high grade serous ovarian cancer through combined inhibition of Polo-like kinase 1 and microtubule dynamicsSabrina Noack, Monika Raab, Yves Matthess, et al.Oncotarget|June 15, 2018
Platelet activation parameters and platelet-leucocyte-conjugate formation in glioblastoma multiforme patientsSascha Marx, Maximilian Splittstöhser, Frederik Kinnen, et al.Oncotarget|June 15, 2018
Inhibition of Fas associated phosphatase 1 (Fap1) facilitates apoptosis of colon cancer stem cells and enhances the effects of oxaliplatinWeiqi Huang, Ling Bei, Elizabeth A EklundOncotarget|June 15, 2018
Epigenetic dysregulation of TET2 in human glioblastomaMaría G García, Antonella Carella, Rocío G Urdinguio, et al.Oncotarget|June 15, 2018
A novel combinatorial treatment option for metastatic uveal melanomaDudi Shneor, Shay Tayeb, Jacob Pe'er, et al.Oncotarget|June 15, 2018
Loss-of-function mutations in Zn-finger DNA-binding domain of HNF4A cause aberrant transcriptional regulation in liver cancerHiroaki Taniguchi, Akihiro Fujimoto, Hidetoshi Kono, et al.Oncotarget|June 15, 2018
The outweigh of toxicity versus risk of recurrence for adjuvant interferon therapy: a survey in German melanoma patients and their treating physiciansKatharina C Kähler, Christine Blome, Andrea Forschner, et al.Pageof 2,517